Trials / Completed
CompletedNCT02890472
Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study
Research of Thymix Dysgenesis in Prenatal Examination of Deletion 22q11 Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
22q11.2 microdeletion seems the prenatally under-diagnosed . Indeed , there is a mismatch between the series on the heart rate of 22q11.2 antenatal 84% against 30% in the adult series despite a perinatal mortality of 16% suggesting opportunities for improvement in the prenatal diagnosis of fetus with a microdeletion 22q11.2 , especially without heart disease
Conditions
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2020-07-01
- Completion
- 2020-12-31
- First posted
- 2016-09-07
- Last updated
- 2021-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02890472. Inclusion in this directory is not an endorsement.